Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.46 GBX | +0.04% | +2.79% | +48.78% |
May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+48.78% | 85.86M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.48% | 22.67B | |
-9.68% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- POLB Stock
- News Poolbeg Pharma PLC
- Poolbeg Pharma's Nonexecutive Chair Transitions to Executive Role